Infinity Historical Balance Sheet
| INFIQ Stock | 0.0001 0.00 0.00% |
Trend analysis of Infinity Pharmaceuticals balance sheet accounts such as Other Current Liabilities of 9 M or Total Current Liabilities of 13.1 M provides information on Infinity Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Infinity Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Infinity Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Infinity Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Infinity Pharmaceuticals is a good buy for the upcoming year.
Infinity |
About Infinity Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Infinity Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Infinity Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Infinity Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Infinity currently owns. An asset can also be divided into two categories, current and non-current.
Infinity Pharmaceuticals Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Infinity Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Infinity Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Infinity Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Infinity Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.Accumulated Other Comprehensive Income
Gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized.Most accounts from Infinity Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Infinity Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Infinity Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Infinity Stock, please use our How to Invest in Infinity Pharmaceuticals guide.At this time, Infinity Pharmaceuticals' Liabilities And Stockholders Equity is relatively stable compared to the past year. As of 12/02/2024, Total Current Assets is likely to grow to about 55.9 M, while Total Current Liabilities is likely to drop slightly above 13.1 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 1.4M | 917K | 825.3K | 784.0K | Total Assets | 84.8M | 42.2M | 48.5M | 59.2M |
Infinity Pharmaceuticals balance sheet Correlations
Click cells to compare fundamentals
Infinity Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Infinity Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Infinity Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Infinity Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Infinity Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Infinity Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Infinity Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Infinity Pharmaceuticals to buy it.
The correlation of Infinity Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Infinity Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Infinity Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Infinity Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Infinity Stock Analysis
When running Infinity Pharmaceuticals' price analysis, check to measure Infinity Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuticals is operating at the current time. Most of Infinity Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infinity Pharmaceuticals' price. Additionally, you may evaluate how the addition of Infinity Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.